NANE_ASPNN
ID NANE_ASPNN Reviewed; 405 AA.
AC A0A6G9KJC3;
DT 02-JUN-2021, integrated into UniProtKB/Swiss-Prot.
DT 12-AUG-2020, sequence version 1.
DT 03-AUG-2022, entry version 7.
DE RecName: Full=N-methyltransferase nanE {ECO:0000303|PubMed:32182055};
DE EC=2.1.1.- {ECO:0000269|PubMed:32182055};
DE AltName: Full=Nanangelenin A biosynthesis cluster protein E {ECO:0000303|PubMed:32182055};
GN Name=nanE {ECO:0000303|PubMed:32182055}; ORFNames=FE257_001453;
OS Aspergillus nanangensis.
OC Eukaryota; Fungi; Dikarya; Ascomycota; Pezizomycotina; Eurotiomycetes;
OC Eurotiomycetidae; Eurotiales; Aspergillaceae; Aspergillus.
OX NCBI_TaxID=2582783;
RN [1]
RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, AND PATHWAY.
RC STRAIN=CBS 146238 / FRR 6048 / MST FP2251;
RX PubMed=32182055; DOI=10.1021/jacs.0c01605;
RA Li H., Gilchrist C.L.M., Phan C.S., Lacey H.J., Vuong D., Moggach S.A.,
RA Lacey E., Piggott A.M., Chooi Y.H.;
RT "Biosynthesis of a new benzazepine alkaloid nanangelenin A from Aspergillus
RT nanangensis involves an unusual l-kynurenine-incorporating NRPS catalyzing
RT regioselective lactamization.";
RL J. Am. Chem. Soc. 142:7145-7152(2020).
CC -!- FUNCTION: N-methyltransferase; part of the gene cluster that mediates
CC the biosynthesis of the benzazepine alkaloid nanangelenin A which
CC contains an unprecedented 3,4-dihydro-1-benzazepine-2,5-dione-N-prenyl-
CC N-acetoxy-anthranilamide scaffold (PubMed:32182055). The first step of
CC nanangelenin biosynthesis is catalyzed by the indoleamine 2,3-
CC dioxygenase nanC which produces N-formyl-kynurenine through the
CC catabolism of tryptophan (PubMed:32182055). The two-module NRPS nanA
CC then utilizes anthranilate (Ant) and L-kynurenine (L-Kyn) to assemble
CC the dipeptide product nanangelenin B (PubMed:32182055). The first
CC adenylation domain of nanA (A1) loads anthranilate onto the T1 domain,
CC while A2 loads kynurenine, generated through spontaneous nonenzymatic
CC deformylation of the nanC-supplied N-formyl-kynurenine
CC (PubMed:32182055). The peptide bond formation between the tethered
CC amino acids is catalyzed by the first condensation domain (C1) between
CC anthranilate's carbonyl carbon and kynurenine's aliphatic primary amine
CC (PubMed:32182055). The second C domain (C2) catalyzes the final
CC cyclization event between the aromatic amine of kynurenine and the
CC tethered carbonyl carbon, yielding nanangelenin B (PubMed:32182055).
CC The terminal T3 domain enhances the catalytic efficiency of C2,
CC suggesting the T2-tethered Ant-L-Kyn is transferred to T3 prior to
CC cyclization by C2 (PubMed:32182055). Once released from nanA,
CC nanangelenin B is then prenylated by the prenyltransferase nanD to form
CC nanangelenin C (PubMed:32182055). Nanangelenin C is then N-hydroxylated
CC by the FAD-dependent monooxygenase nanF and further acetylated by the
CC acetyltransferase nanB to yield nanangelenin F (PubMed:32182055).
CC Finally, the N-methyltransferase nanE methylates the amide nitrogen of
CC 1-benzazepine to convert nanangelenin F into nanangelenin A
CC (PubMed:32182055). NanE is also able to methylate most of the
CC intermediates of the pathway such as nanangelenin B and nanangelenin C
CC to produce nanangelenin D and nanangelenin E, respectively
CC (PubMed:32182055). {ECO:0000269|PubMed:32182055}.
CC -!- PATHWAY: Secondary metabolite biosynthesis.
CC {ECO:0000269|PubMed:32182055}.
CC -!- SIMILARITY: Belongs to the class I-like SAM-binding methyltransferase
CC superfamily. Cation-independent O-methyltransferase family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; MT024570; QIQ51366.1; -; Genomic_DNA.
DR AlphaFoldDB; A0A6G9KJC3; -.
DR SMR; A0A6G9KJC3; -.
DR GO; GO:0008171; F:O-methyltransferase activity; IEA:InterPro.
DR GO; GO:0032259; P:methylation; IEA:UniProtKB-KW.
DR Gene3D; 1.10.10.10; -; 1.
DR Gene3D; 3.40.50.150; -; 1.
DR InterPro; IPR016461; COMT-like.
DR InterPro; IPR001077; O_MeTrfase_dom.
DR InterPro; IPR029063; SAM-dependent_MTases_sf.
DR InterPro; IPR036388; WH-like_DNA-bd_sf.
DR InterPro; IPR036390; WH_DNA-bd_sf.
DR Pfam; PF00891; Methyltransf_2; 1.
DR SUPFAM; SSF46785; SSF46785; 1.
DR SUPFAM; SSF53335; SSF53335; 1.
DR PROSITE; PS51683; SAM_OMT_II; 1.
PE 3: Inferred from homology;
KW Methyltransferase; S-adenosyl-L-methionine; Transferase.
FT CHAIN 1..405
FT /note="N-methyltransferase nanE"
FT /id="PRO_0000452969"
FT BINDING 238..239
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250|UniProtKB:O04385"
FT BINDING 261
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01020"
FT BINDING 290..291
FT /ligand="S-adenosyl-L-methionine"
FT /ligand_id="ChEBI:CHEBI:59789"
FT /evidence="ECO:0000250|UniProtKB:O04385"
SQ SEQUENCE 405 AA; 44974 MW; B168C0C7B55713F5 CRC64;
MTIANTPAEL LASSISTLAS RYAEKVQAGE NADTEIASIV SACKDLDALV TPPESWNDRM
AMSYTISTAI ALLLNWDVFQ ILAAQAKPTS LETLATSCGC SKSLLRCALR EAVAHRMLDE
LSPETYALNS RSSCLLDENK AAWIHYLTDI GLVTAAYLPK YVKSINGKIP EHSHRIALQM
AFNVDETFYE FLHRKDPKRG VNFDKAMQRH IKGDAQASIE SVFDFSILRP GAVVVDVGGG
KGHHCIRIAK KHPHLSFIIQ DYEANGPSDG EDTLPEALAR RVRWQRHNFH HKQPMDGADV
YLLSNILMDN TVSDCNRILT NIVDAMVPNH SVLLVDDAID TLSEDSHSAY SSSMNLHMLS
CFGTLFRTQE DWLMLFSEVA GGKLSIVSSW MIDAGRMIFA LRRKF